The customer observed falsely elevated magnesium results for two patient samples tested on the architect c4000 analyzer.The following data was provided: sid (b)(6): initial result 6.7, repeat 1.9, 1.9 mg/dl (repeated with sid (b)(6)).Sid (b)(6): initial result 2.7, repeat 1.1, 1.0 mg/dl (repeated with sid (b)(6)).The customer uses normal range 1.6 - 2.6 mg/dl.No impact to patient management was reported.
|
A review of tickets determined that there is normal complaint activity for lot 04426un19.Trending review determined no adverse trend for falsely elevated results for the product.Return testing was not completed as returns were not available.Historical performance of reagent lot 04426un19 was evaluated using world wide data from abbottlink.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for lot 04426un19 is within the established control limits.Therefore, no unusual reagent lot performance was identified.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no product deficiency was identified for the architect magnesium reagent, lot 04426un19.
|